Skip to main content
. 2024 Feb 3;23:859–869. doi: 10.1016/j.csbj.2024.01.023

Fig. 3.

Fig. 3

Results of Mascot-based immunopeptide identification from 18 patients with cancer. The (a) individual count of detected CandiSeqs in different cancer types; (b) the length distribution of CandiSeqs; (c) count of HCS in CandiSeqs; (d) count and (e) ratio of HCS in CandiSeq at different cutoff values of Mascot ion score.